Lung nodules evaluation

Lung nodules, commonly identified on chest imaging or during lung cancer screening, represent a diagnostic challenge due to their wide spectrum of potential causes. While many nodules are benign, resulting from infections, inflammation, or healed granulomas, a significant minority can indicate early-stage malignancy. Careful evaluation of lung nodules is therefore essential for timely diagnosis and appropriate management. The process begins with assessment of radiographic characteristics, including size, margins, density, and growth over serial imaging. Low-dose computed tomography has revolutionized screening, particularly in high-risk individuals such as smokers, by enabling earlier detection of subtle nodular changes. Risk stratification models that combine imaging data with clinical factors like age, smoking history, and comorbidities help guide next steps. For suspicious or enlarging nodules, invasive diagnostic tools are employed. Bronchoscopy with advanced navigation techniques, transthoracic needle aspiration, or video-assisted thoracoscopic surgery allow tissue sampling with increasing safety and accuracy. Molecular testing of biopsy specimens is now frequently incorporated, helping identify genetic alterations that influence treatment decisions in lung cancer. Importantly, multidisciplinary teams—including radiologists, pulmonologists, and thoracic surgeons—ensure that recommendations are personalized, avoiding both under-treatment and unnecessary invasive procedures. Lung nodules evaluation thus represents a critical intersection between prevention, diagnosis, and precision medicine, contributing to earlier intervention and improved survival outcomes in respiratory care.